← Back to ADHDinfoNinja

🔬 Scientific Studies

ADHD scientific studies from The Lancet Psychiatry, JAMA, Nature, Cochrane Reviews, Frontiers, PubMed. Landmark research 2011-2025.

European Psychiatry (1)

Prevalence of ADHD: systematic review and meta-analysis (117 studies) by Popit S, Serod K, Locatelli I, Stuhec M
The estimates of attention-deficit hyperactivity disorder (ADHD) prevalence across various studies are significantly variable, contributing to uncertainty in ADHD prevalence estimation. Previous systematic reviews and meta-analyses have attributed this variability primarily to the methodological cha

Frontiers in Psychiatry (2)

ADHD in adulthood: clinical presentation, comorbidities, and treatment perspectives by Multiple authors
Attention-deficit/hyperactivity disorder (ADHD) in adults has become an increasingly recognized clinical entity, with growing attention in research and healthcare settings. ADHD can significantly affect multiple domains of adult functioning, including education, employment, interpersonal relationshi
Short-term and long-term effect of non-pharmacotherapy for adults with ADHD: network meta-analysis by Multiple authors

J Child Psychol Psychiatry (4)

Annual research review: meta-analysis of worldwide prevalence of mental disorders in children by Polanczyk GV, Salum GA, Sugaya LS et al.
The literature on the prevalence of mental disorders affecting children and adolescents has expanded significantly over the last three decades around the world. Despite the field having matured significantly, there has been no meta-analysis to calculate a worldwide-pooled prevalence and to empirical
Emotional dysregulation in ADHD: implications for clinical recognition and intervention by Faraone SV, Rostain AL, Blader J et al.
Because emotional symptoms are common in attention-deficit/hyperactivity disorder (ADHD) patients and associate with much morbidity, some consider it to be a core feature rather than an associated trait. Others argue that emotional symptoms are too nonspecific for use as diagnostic criteria. This de
Life span studies of ADHD: conceptual challenges and predictors by Caye A, Swanson J, Thapar A et al.
The impact of chronic stressors like the COVID-19 pandemic is likely to be magnified in adolescents with pre-existing mental health risk, such as attention-deficit/hyperactivity disorder (ADHD). This study examined changes in and predictors of adolescent mental health from before to during the COVID
Practitioner review: current best practice in parent training for ADHD by Daley D, Van Der Oord S, Ferrin M et al.
Behavioural interventions are recommended for use with children and young people with attention deficit hyperactivity disorder (ADHD); however, specific guidance for their implementation based on the best available evidence is currently lacking.

JAACAP (5)

Biomarkers and ADHD: systematic review and meta-analyses by Scassellati C et al.
Effects of ADHD medication on quality of life: systematic review and meta-analysis by Bellato A, Perrott NJ, Marzulli L et al.
Long-term outcomes of ADHD and conduct disorder: systematic review and meta-analysis by Erskine HE et al.
Attention-deficit/hyperactivity disorder (ADHD) and conduct disorder (CD) are common externalizing disorders. Despite previous research demonstrating that both are longitudinally associated with adverse outcomes, there have been no systematic reviews examining all of the available evidence link
Screening tools for ADHD in children and adolescents: systematic review by Mulraney M et al.
This study tested the "intervention as prevention" hypothesis: that treatment of childhood psychopathology in the community might reduce risk for adult psychopathology.
Sensory processing in ADHD vs controls: systematic review and meta-analysis by Jurek L et al.

JAMA / JAMA Psychiatry / JAMA Network Open (8)

ADHD medications and long-term risk of cardiovascular diseases by Zhang L, Li L, Andell P et al.
Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased substantially over the past decades. However, the potential risk of cardiovascular disease (CVD) associated with long-term ADHD medication use remains unclear.
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults by Habel LA, Cooper WO, Sox CM et al.
ADHD pharmacotherapy and mortality in individuals with ADHD by Li L, Zhu N, Zhang L et al.
Association of ADHD with mortality: a systematic review and meta-analysis by Sun S, Kuja-Halkola R, Faraone SV et al.
Long-term cardiovascular effects of ADHD medications: balancing benefits and risks by Cortese S, Coghill D
Methylphenidate and short-term cardiovascular risk by Garcia-Argibay M, Burkner PC, Lichtenstein P et al.
Screen time and ADHD symptoms in children and adolescents: meta-analysis by Liu J et al.
Children's exposure to screen time has been associated with poor mental health outcomes, yet the role of genetic factors remains largely unknown.
Shared genetic risk in the association of screen time with psychiatric problems in children by Zhang Y, Choi KW, Delaney SW et al.
Children's exposure to screen time has been associated with poor mental health outcomes, yet the role of genetic factors remains largely unknown.

Molecular Psychiatry (2)

Computerized cognitive training in ADHD: meta-analysis with blinded outcomes by Westwood SJ, Parlatini V, Rubia K et al.
Stimulant dose and dosing strategy on treatment outcomes in ADHD: meta-analysis by Farhat LC, Flores JM, Behling E et al.
Clinical guidelines currently recommend practitioners titrate stimulant medications, i.e., methylphenidate (MPH) and amphetamines (AMP), to the dose that maximizes symptom control without eliciting intolerable adverse events (AEs) when treating attention-deficit/hyperactivity disorder (ADHD) in scho

Nature / Nature Genetics (4)

Discovery of the first genome-wide significant risk loci for ADHD by Demontis D, Walters RK, Martin J et al.
Attention deficit/hyperactivity disorder (ADHD) is a highly heritable childhood behavioral disorder affecting 5% of children and 2.5% of adults. Common genetic variants contribute substantially to ADHD susceptibility, but no variants have been robustly associated with ADHD. We report a genome-wide a
Genome-wide analyses of ADHD identify 27 risk loci, refine biology and provide insight by Demontis D, Walters GB, Athanasiadis G et al.
Genome-wide CNV study associates mGluR gene networks with ADHD by Elia J, Glessner JT, Wang K et al.
Ollier disease and Maffucci syndrome are non-hereditary skeletal disorders characterized by multiple enchondromas (Ollier disease) combined with spindle cell hemangiomas (Maffucci syndrome). We report somatic heterozygous mutations in IDH1 (c.394C>T encoding an R132C substitution and c.395G>A
World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions by Faraone SV, Banaschewski T, Coghill D et al.

Other Journals (4)

Cardiovascular safety of stimulants in children with ADHD: nationwide prospective cohort by Dalsgaard S, Kvist AP, Leckman JF et al.
Previous studies suggest that the unexplained sudden and severe onset of obsessive-compulsive disorder (OCD) and/or tics may be infection or immune precipitated. Beta lactam antibiotics may be neuroprotective beyond their antimicrobial efficacy. We examine the preliminary safety and efficacy of cefd
Global prevalence of ADHD in children and adolescents: umbrella review of meta-analyses by Ayano G, Demelash S, Gizachew Y et al.
Emerging epidemiological data suggest that hundreds of primary studies have examined the prevalence of ADHD in children and adolescents and dozens of systematic view and meta-analyses studies have been conducted on the subject. The purpose of this umbrella review is to provide a robust synthesis of
Non-pharmacological interventions for ADHD: systematic review and meta-analyses of RCTs by Sonuga-Barke EJS, Brandeis D, Cortese S et al.
Nonpharmacological treatments are available for attention deficit hyperactivity disorder (ADHD), although their efficacy remains uncertain. The authors undertook meta-analyses of the efficacy of dietary (restricted elimination diets, artificial food color exclusions, and free fatty acid supplementat
Prevalence of adult ADHD: global systematic review and meta-analysis by Song P, Zha M, Yang Q et al.

PLoS ONE / PLoS Medicine (1)

Screen-time is associated with inattention problems in preschoolers: CHILD cohort by Tamana SK, Ezeugwu V, Chikuma J et al.

The Lancet Psychiatry (7)

ADHD in children and young people: prevalence, care pathways, and service provision by Sayal K, Prasad V, Daley D et al.
Attention-deficit hyperactivity disorder (Lancet Seminar) by Posner J, Polanczyk GV, Sonuga-Barke E
Attention-deficit hyperactivity disorder (ADHD), like other psychiatric disorders, represents an evolving construct that has been refined and developed over the past several decades in response to research into its clinical nature and structure. The clinical presentation and course of the disorder h
Comparative cardiovascular safety of ADHD medications: systematic review and network meta-analysis by Cortese S et al.
Concerns about the cardiovascular safety of medications used for the treatment of attention-deficit hyperactivity disorder (ADHD) remain. We aimed to compare the effects of pharmacological treatments for ADHD on haemodynamic values and electrocardiogram (ECG) parameters in children, adolescents, and
Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults by Ostinelli EG, Schulze M, Zangani C et al.
The comparative benefits and harms of available interventions for ADHD in adults remain unclear. We aimed to address these important knowledge gaps.
Comparative efficacy and tolerability of ADHD medications in children, adolescents, and adults: network meta-analysis by Cortese S, Adamo N, Del Giovane C et al.
The benefits and safety of medications for attention-deficit hyperactivity disorder (ADHD) remain controversial, and guidelines are inconsistent on which medications are preferred across different age groups. We aimed to estimate the comparative efficacy and tolerability of oral medications for ADHD
Method of adult diagnosis influences estimated persistence of childhood ADHD by Sibley MH, Swanson JM, Arnold LE et al.
Structural brain measures among children with and without ADHD in the ABCD study by Bernanke J, Luna A, Chang L et al.
Structural neuroimaging research has identified a variety of abnormalities in cortical and subcortical structures in children with ADHD. However, studies to date have not employed large, non-referred samples, complete with data on potential confounding variables. Here, we tested for differences in s

Translational Psychiatry (1)

Association of screen time with ADHD symptoms: the mediating role of brain structure by Multiple authors
The association among screen time, attention-deficit/hyperactivity disorder (ADHD) symptom development, and brain structure, and the neural mechanisms underlying the association between screen time and ADHD symptoms remain unclear. This study examines the relationships between the three using large-

ADHDinfoNinja · adhd.ninja · Contact

Related Topics

💊 Medications📰 ADHD News📚 Books